Product Overview
Dragon Pharma Superdrol is methyldrostanolone, the methylated anabolic that most people know as methasterone, presented as 10 mg tablets in a 100 tablet pack. The molecule is dihydrotestosterone carrying methyl groups at the 2 and 17 positions, and that is what produces the compound's signature: dense, dry gains with no aromatisation and no water under the skin. The 17-alpha-methyl group is also what makes the molecule survive first pass through the liver, and that same group is why the tablet is the most hepatotoxic item in the oral range. The brand lists the same substance as an injectable solution in Superdrol Inj for users who want to avoid the oral route.
Methasterone appeared around 2005 as a designer steroid and was later the subject of an FDA warning and a prohibition, so it is a controlled anabolic agent rather than a supplement. It is grouped under class S1 of the WADA list. Metabolites are detectable in urine typically for three to ten days, with individual papers reporting up to eleven, which is a short window compared with injectable esters but still long enough to matter for testing. Because the compound is not aromatising, an aromatase inhibitor does not belong in this cycle; the usual oral companion for size and water instead belongs to other molecules, such as Dianabol 20, and the two are not interchangeable.
The segment where the tablet makes sense is a short intensification phase, not a base. Users add it to a cycle that already has an injectable foundation, run it for roughly three weeks and stop, because the gains arrive quickly and the liver values move just as quickly. Anyone weighing it against the other methylated orals in the line, Methyl-1-Test, Oxymetholon or Halotestin, should read them as three different risk profiles rather than as three strengths of the same thing.
Dosage Protocol
The tablet is strong enough that the reference range sits at the bottom of what most people expect. Doses below come from the collected reference data for methasterone, and the cycle length matters more than the daily figure.
| Beginner | 10 mg daily across three weeks, split into two doses; the lowest effective dose is the sensible entry point |
| Intermediate | 10-20 mg daily across three to four weeks; doses past 20 mg a day are used only rarely |
| Advanced | Up to 30 mg a day, and no longer than four weeks; this is the top of the reference recommendations and complaints about the liver rise sharply past it |
| Female | No confirmed protocol exists; virilization is a real risk on any DHT-derived oral, so no safe female schedule can be quoted |
| Administration | Oral tablets taken with food, divided into two doses a day because the compound is short-acting; the tablet should not be taken late at night |
Splitting the daily amount into two tablets is the standard practice and it keeps the level steadier than one larger dose. The cycle stops at the end of the block rather than being extended, because the limiting factor is the liver, not tolerance to the training effect.
Suggested Protocols
Superdrol is used as an addition to an existing cycle. Each plan below keeps the methylated oral to a short block and leaves the injectable to carry the length.
The rule is not to run methasterone beside another methylated oral. Sequences, not layers, are what the reference material describes.
What to Expect
- Strength arrives first. Heavier working sets are felt within days, which is the reason the block is kept short.
- Dry appearance. No aromatisation means no watery look; the body weight that comes on is closer to lean tissue than to fluid.
- No estrogenic swelling. Gynecomastia is atypical here because the compound does not convert, so an aromatase inhibitor is not part of the plan.
- Joints feel drier and less comfortable. A common complaint on low-estrogen compounds, especially on a deficit.
- Flat mood and low energy. Suppression of natural production begins in the first weeks and the low-estrogen state adds to it.
- Liver values rise. Enzyme elevation is expected rather than surprising, and control testing is part of the block.
- Limitation. Clinical reports describe liver injury and cholestatic jaundice even on short courses. That is a property of the molecule, and it does not disappear at a lower dose.
Side Effects and Management
The hepatic and lipid side of this compound is not cosmetic, and neither is the suppression. Everything listed below is dose-related, and bloodwork is what separates a controlled block from a gamble.
Post-Cycle Therapy
The tablet leaves the body quickly, and the suppression it produces does not, so therapy is planned before the block begins rather than after it ends.
